| Mrs Rise Lynne Kester, APRN | |
|
1000 Hospital Cir, Kingfisher, OK 73750-5002 | |
| (405) 375-6355 | |
| (405) 375-6374 |
| Full Name | Mrs Rise Lynne Kester |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 1000 Hospital Cir, Kingfisher, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063637130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | R0028101 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Accentra Home Health - Northwestern | Oklahoma city, OK | Home health agency |
| Mercy Home Health | Oklahoma city, OK | Home health agency |
| Russell-murray Hospice, Inc | El reno, OK | Hospice |
| Mercy Hospital Kingfisher, Inc | Kingfisher, OK | Hospital |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| O U Medical Center | Oklahoma city, OK | Hospital |
| Mercy Hospital Watonga, Inc | Watonga, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Oklahoma Communities | 1153468921 | 485 |
News Archive
Carl Backes, Jr., MD, a neonatologist and current cardiology fellow at Nationwide Children's Hospital, has been awarded $35,000 from the March of Dimes Ohio Chapter for his project to expand an outpatient methadone education program.
The New York Times examines the Cuban network of sanitariums created to house and treat people living with HIV, "to keep the infected from having sex with anyone uninfected and to help them die comfortably."
The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.
The molecular machinery that helps brain cells migrate to their correct place in the developing brain has been identified by scientists at St. Jude Children's Research Hospital.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
› Verified 1 days ago
| Entity Name | Mercy Clinic Oklahoma Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386874550 PECOS PAC ID: 1153468921 Enrollment ID: O20091027000755 |
News Archive
Carl Backes, Jr., MD, a neonatologist and current cardiology fellow at Nationwide Children's Hospital, has been awarded $35,000 from the March of Dimes Ohio Chapter for his project to expand an outpatient methadone education program.
The New York Times examines the Cuban network of sanitariums created to house and treat people living with HIV, "to keep the infected from having sex with anyone uninfected and to help them die comfortably."
The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.
The molecular machinery that helps brain cells migrate to their correct place in the developing brain has been identified by scientists at St. Jude Children's Research Hospital.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rise Lynne Kester, APRN 1000 Hospital Cir, Kingfisher, OK 73750-5002 Ph: (405) 375-6355 | Mrs Rise Lynne Kester, APRN 1000 Hospital Cir, Kingfisher, OK 73750-5002 Ph: (405) 375-6355 |
News Archive
Carl Backes, Jr., MD, a neonatologist and current cardiology fellow at Nationwide Children's Hospital, has been awarded $35,000 from the March of Dimes Ohio Chapter for his project to expand an outpatient methadone education program.
The New York Times examines the Cuban network of sanitariums created to house and treat people living with HIV, "to keep the infected from having sex with anyone uninfected and to help them die comfortably."
The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.
The molecular machinery that helps brain cells migrate to their correct place in the developing brain has been identified by scientists at St. Jude Children's Research Hospital.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.
› Verified 1 days ago